Држава: Сједињене Америчке Државе
Језик: Енглески
Извор: NLM (National Library of Medicine)
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)
L'Oreal USA Products Inc
TOPICAL
OTC DRUG
OTC monograph not final
YVES SAINT LAURENT TERRE SAHARIENNE BRONZING- OCTINOXATE POWDER L'OREAL USA PRODUCTS INC _Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they_ _comply with applicable regulations and policies. FDA has not evaluated whether this product complies._ ---------- DRUG FACTS ACTIVE INGREDIENT Octinoxate 6% DIRECTIONS Apply before sun exposure. WARNINGS For external use only. Avoid contact with eyes. Discontinue use if signs of irritation or rash appear. Keep out of reach of children. INACTIVE INGREDIENTS talc, synthetic wax, PTFE, nylon-12, polyquaternium-61, magnesium stearate, octyldodecyl stearoyl stearate, dimethicone, pentaerythrityl tetraisostearate, lauroyl lysine, tocopheryl acetate, caprylyl glycol, alumina, aloe barbadensis leaf extract, synthetic fluorphlogopite, squalane; may contain: mica, iron oxides, titanium dioxide, carmine YVES SAINT LAURENT TERRE SAHARIENNE BRONZING octinoxate powder PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:49 9 6 7-521 ROUTE OF ADMINISTRATION TOPICAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH O CTINO XA TE (UNII: 4Y5P7MUD51) (Octino xate - UNII:4Y5P7MUD51) O c tino xa te 0 .6 g in 10 g PACKAG ING L'Oreal USA Products Inc # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:49 9 6 7-521-0 1 1 in 1 CARTON 1 10 g in 1 CASE MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE OTC mo no graph no t final pa rt352 0 8 /0 1/20 11 LABELER - L'Oreal USA Products Inc (002136794) ESTABLISHMENT NAME AD D RE S S ID/FEI BUSINE SS OPE RATIONS Beaute Recherche & Industries 39 8 540 0 0 0 ma nufa c ture Revised: 2/2012 Прочитајте комплетан документ